Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly

NCT00765323 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: Octreotide Implant
DRUG: Sandostatin LAR Depot

Sponsor

Endo Pharmaceuticals